Syapse has been a constant presence in the precision medicine industry, and has recently furthered its involvement in oncology through a partnership with Henry Ford Health Systems. Henry Ford Health System, one of the largest national integrated health systems, will provide cancer outcomes data to Syapse. In return, Syapse will use this data in its software platform, which will enable faster, global learning gained from real-world experiences. Through this agreement, there will be a launch of an oncology precision medicine program, with the hope of providing precision medicine to patients in the greater Midwest.
Jonathan Hirsch, president and founder of Syapse, will be highlighting his company’s efforts at revolutionizing precision cancer care at the 8th Annual Personalized and Precision Medicine Conference. To learn more information, visit: http://personalizedmedicinepartnerships.com/.
In the next few months, Henry Ford Health System will launch the Syapse Precision Medicine Platform software across its cancer care facilities, including the new $10 million destination cancer center in Detroit. Both companies are optimistic that this partnership will advance innovative cancer clinical care, especially for patients in the Midwest. Jonathan Hirsch stated, “We believe that precision medicine will be a core enabling technology for health systems to transform to value-based care.” For more information on this partnership, visit: http://syapse.com/blog/henry-ford-press-release-june-2016/.